AI assistant
Sending…
ACADIA PHARMACEUTICALS INC — Director's Dealing 2021
Oct 1, 2021
31237_dirs_2021-10-01_e7c08bc6-5b79-4744-8899-8cf337aa4fd3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ACADIA PHARMACEUTICALS INC (ACAD)
CIK: 0001070494
Period of Report: 2021-09-29
Reporting Person: GAROFALO ELIZABETH A. (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-09-29 | Common Stock | M | 1918 | — | Acquired | 1918 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-09-29 | Restricted Stock Units | $ | M | 1918 | Acquired | Common Stock (1918) | Direct |
Footnotes
F1: Each restricted stock unit represents a contingent right to receive one share of ACADIA common stock.
F2: The restricted stock units shall vest in two equal annual installments commencing September 29, 2021.
More from ACADIA PHARMACEUTICALS INC
Declaration of Voting Results & Voting Rights Announcements
2026
May 29
Regulatory Filings
2026
May 6
Director's Dealing
2026
Mar 27
Director's Dealing
2026
Mar 27
Director's Dealing
2026
Mar 27
Director's Dealing
2026
Mar 27
Director's Dealing
2026
Mar 27
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 20
Director's Dealing
2026
Mar 20